Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Stomach Neoplasms × Acetylcysteine × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neurofibromatosis 1 2 Carcinoma, Hepatocellular 2 Weight Loss 1 Ulcer 1 Tongue Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Radiation-Induced Mucositis 1 Radiation Pneumonitis 1 Pseudomyxoma Peritonei 1 Primary Graft Dysfunction 1 Ovarian Neoplasms 1 Neoplasms, Cystic, Mucinous, and Serous 1 Muscular Atrophy 1 Mucositis 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Liver Neoplasms 1 Liver Failure, Acute 1 Liver Failure 1 Liver Diseases 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Oxaliplatin 154 Capecitabine 104 Fluorouracil 91 Docetaxel 77 Cisplatin 76 S 1 (combination) 74 Leucovorin 63 Paclitaxel 52 Irinotecan 51 pembrolizumab 34 Trastuzumab 31 apatinib 29 sintilimab 28 Bevacizumab 20 Surgical Procedures, Operative 19 Radiotherapy 19 camrelizumab 15 Ramucirumab 14 Nivolumab 14 titanium silicide 13 tislelizumab 13 Drug Therapy 13 Hyperthermic Intraperitoneal Chemotherapy 12 Folfox protocol 12 Epirubicin 12 Cetuximab 12 Tegafur 10 Carboplatin 10 XELOX 9 HMPL-013 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07245095 2025-11-24

NACSIMET

Hospital General de Mexicali

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡